These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
564 related articles for article (PubMed ID: 26345596)
1. Impact of neoadjuvant chemotherapy on pathologic axillary nodal status in HER-2 positive patients presenting with clinically node-negative disease. Al-Hilli Z; Hieken TJ; Hoskin TL; Heins CN; Boughey JC J Surg Oncol; 2015 Oct; 112(5):453-7. PubMed ID: 26345596 [TBL] [Abstract][Full Text] [Related]
2. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer. Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899 [TBL] [Abstract][Full Text] [Related]
3. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes. Diego EJ; McAuliffe PF; Soran A; McGuire KP; Johnson RR; Bonaventura M; Ahrendt GM Ann Surg Oncol; 2016 May; 23(5):1549-53. PubMed ID: 26727919 [TBL] [Abstract][Full Text] [Related]
4. Influence of neoadjuvant chemotherapy on HER2/neu status in invasive breast cancer. Li P; Liu T; Wang Y; Shao S; Zhang W; Lv Y; Yi J; Wang Z Clin Breast Cancer; 2013 Feb; 13(1):53-60. PubMed ID: 23103368 [TBL] [Abstract][Full Text] [Related]
5. Impact of Residual Nodal Disease Burden on Technical Outcomes of Sentinel Lymph Node Biopsy for Node-Positive (cN1) Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Laws A; Hughes ME; Hu J; Barry WT; Dominici L; Nakhlis F; Barbie T; Duggan M; Weiss A; Rhei E; Carter K; Nimbkar S; Schnitt SJ; King TA Ann Surg Oncol; 2019 Nov; 26(12):3846-3855. PubMed ID: 31222687 [TBL] [Abstract][Full Text] [Related]
6. Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer. Hieken TJ; Boughey JC; Jones KN; Shah SS; Glazebrook KN Ann Surg Oncol; 2013 Oct; 20(10):3199-204. PubMed ID: 23846781 [TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507 [TBL] [Abstract][Full Text] [Related]
8. Impact of Neoadjuvant Chemotherapy on Nodal Disease and Nodal Surgery by Tumor Subtype. Al-Hilli Z; Hoskin TL; Day CN; Habermann EB; Boughey JC Ann Surg Oncol; 2018 Feb; 25(2):482-493. PubMed ID: 29181679 [TBL] [Abstract][Full Text] [Related]
9. Outcomes of clinically node-negative breast cancer without axillary dissection: can preserved axilla be safely treated with radiation after a positive sentinel node biopsy? Sanuki N; Takeda A; Amemiya A; Ofuchi T; Ono M; Ogata H; Yamagami R; Hatayama J; Eriguchi T; Kunieda E Clin Breast Cancer; 2013 Feb; 13(1):69-76. PubMed ID: 23062706 [TBL] [Abstract][Full Text] [Related]
10. Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer. Yagata H; Yamauchi H; Tsugawa K; Hayashi N; Yoshida A; Kajiura Y; In R; Matsuda N; Nakamura S Clin Breast Cancer; 2013 Dec; 13(6):471-7. PubMed ID: 24267732 [TBL] [Abstract][Full Text] [Related]
11. Predicting Non-sentinel Lymph Node Metastases in Patients with a Positive Sentinel Lymph Node After Neoadjuvant Chemotherapy. Barron AU; Hoskin TL; Boughey JC Ann Surg Oncol; 2018 Oct; 25(10):2867-2874. PubMed ID: 29956095 [TBL] [Abstract][Full Text] [Related]
12. Pathologic complete response after neoadjuvant chemotherapy in HER2-overexpressing breast cancer according to hormonal receptor status. Tanioka M; Sasaki M; Shimomura A; Fujishima M; Doi M; Matsuura K; Sakuma T; Yoshimura K; Saeki T; Ohara M; Tsurutani J; Watatani M; Takano T; Kawabata H; Mukai H; Naito Y; Hirokaga K; Takao S; Minami H Breast; 2014 Aug; 23(4):466-72. PubMed ID: 24742606 [TBL] [Abstract][Full Text] [Related]
13. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Kuehn T; Bauerfeind I; Fehm T; Fleige B; Hausschild M; Helms G; Lebeau A; Liedtke C; von Minckwitz G; Nekljudova V; Schmatloch S; Schrenk P; Staebler A; Untch M Lancet Oncol; 2013 Jun; 14(7):609-18. PubMed ID: 23683750 [TBL] [Abstract][Full Text] [Related]
14. Normal Axillary Ultrasound Excludes Heavy Nodal Disease Burden in Patients with Breast Cancer. Jackson RS; Mylander C; Rosman M; Andrade R; Sawyer K; Sanders T; Tafra L Ann Surg Oncol; 2015 Oct; 22(10):3289-95. PubMed ID: 26224404 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer. Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475 [TBL] [Abstract][Full Text] [Related]
16. Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor-Positive, HER2 Negative Patients Likely to Benefit from Neoadjuvant Chemotherapy. Petruolo OA; Pilewskie M; Patil S; Barrio AV; Stempel M; Wen HY; Morrow M Ann Surg Oncol; 2017 Sep; 24(9):2556-2562. PubMed ID: 28560596 [TBL] [Abstract][Full Text] [Related]
17. Predicting Post Neoadjuvant Axillary Response Using a Novel Convolutional Neural Network Algorithm. Ha R; Chang P; Karcich J; Mutasa S; Van Sant EP; Connolly E; Chin C; Taback B; Liu MZ; Jambawalikar S Ann Surg Oncol; 2018 Oct; 25(10):3037-3043. PubMed ID: 29978368 [TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy is a reliable method for lymph node evaluation in neoadjuvant chemotherapy-treated patients with breast cancer. Koslow SB; Eisenberg RE; Qiu Q; Chen Z; Swistel A; Shin SJ Am Surg; 2014 Feb; 80(2):171-7. PubMed ID: 24480218 [TBL] [Abstract][Full Text] [Related]
19. Patterns in the Use of Axillary Operations for Patients with Node-Positive Breast Cancer After Neoadjuvant Chemotherapy: A National Cancer Database (NCDB) Analysis. Srour MK; Tseng J; Luu M; Alban RF; Giuliano AE; Chung A Ann Surg Oncol; 2019 Oct; 26(10):3305-3311. PubMed ID: 31342364 [TBL] [Abstract][Full Text] [Related]
20. Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study. Morency D; Dumitra S; Parvez E; Martel K; Basik M; Robidoux A; Poirier B; Holloway CMB; Gaboury L; Sideris L; Meterissian S; Boileau JF Ann Surg Oncol; 2019 Dec; 26(13):4337-4345. PubMed ID: 31605348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]